These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


195 related items for PubMed ID: 12970089

  • 1. Cellular accumulation of anandamide: consensus and controversy.
    Hillard CJ, Jarrahian A.
    Br J Pharmacol; 2003 Nov; 140(5):802-8. PubMed ID: 12970089
    [Abstract] [Full Text] [Related]

  • 2. Accumulation of anandamide: evidence for cellular diversity.
    Hillard CJ, Jarrahian A.
    Neuropharmacology; 2005 Jun; 48(8):1072-8. PubMed ID: 15910883
    [Abstract] [Full Text] [Related]

  • 3. Further evidence for the existence of a specific process for the membrane transport of anandamide.
    Ligresti A, Morera E, Van Der Stelt M, Monory K, Lutz B, Ortar G, Di Marzo V.
    Biochem J; 2004 May 15; 380(Pt 1):265-72. PubMed ID: 14969584
    [Abstract] [Full Text] [Related]

  • 4. Anandamide uptake explained?
    Fowler CJ.
    Trends Pharmacol Sci; 2012 Apr 15; 33(4):181-5. PubMed ID: 22297258
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Ceramide binding to anandamide increases its half-life and potentiates its cytotoxicity in human neuroblastoma cells.
    Di Scala C, Mazzarino M, Yahi N, Varini K, Garmy N, Fantini J, Chahinian H.
    Chem Phys Lipids; 2017 Jun 15; 205():11-17. PubMed ID: 28389107
    [Abstract] [Full Text] [Related]

  • 12. Effects of homologues and analogues of palmitoylethanolamide upon the inactivation of the endocannabinoid anandamide.
    Jonsson KO, Vandevoorde S, Lambert DM, Tiger G, Fowler CJ.
    Br J Pharmacol; 2001 Aug 15; 133(8):1263-75. PubMed ID: 11498512
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Selective inhibition of anandamide cellular uptake versus enzymatic hydrolysis--a difficult issue to handle.
    Fowler CJ, Tiger G, Ligresti A, López-Rodríguez ML, Di Marzo V.
    Eur J Pharmacol; 2004 May 10; 492(1):1-11. PubMed ID: 15145699
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Transport of endocannabinoids across the plasma membrane and within the cell.
    Fowler CJ.
    FEBS J; 2013 May 10; 280(9):1895-904. PubMed ID: 23441874
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cellular transport of anandamide, 2-arachidonoylglycerol and palmitoylethanolamide--targets for drug development?
    Fowler CJ, Jacobsson SO.
    Prostaglandins Leukot Essent Fatty Acids; 2002 May 10; 66(2-3):193-200. PubMed ID: 12052035
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.